Crossmark

CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy

Crossref DOI link: https://doi.org/10.1007/s00432-019-02865-8

Published Online: 2019-02-18

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Han, Yue

Sun, Fumou

Zhang, Xinrong

Wang, Tong

Jiang, Jiahao

Cai, Jialing

Gao, Qi

Hezam, Kamal

Liu, Yali

Xie, Jiajun

Wang, Min

Zhang, Juan https://orcid.org/0000-0002-1475-719X
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (NSFC81473125)

Natural Science Foundation of Jiangsu Province (BK20161459)

Jiangsu Province Qinglan Project (2014)
License Information

Text and Data Mining valid from 2019-02-18
More Information

Article History

Received: 22 August 2018

Accepted: 13 February 2019

First Online: 18 February 2019

Compliance with ethical standards

:

: The authors declare no competing financial interests.

: All experimental procedures were conducted in conformity with institutional guidelines for the care and use of laboratory animals in Yangzhou University, Yangzhou, China, and they conformed to the National Institutes of Regulations for the Administration of Affairs Concerning Experimental Animals.